bmi requirements for glp 1 Pediatric obesity management algorithm. BMI, body mass index; GLP1, GLP-1 agonists and changes in
Description
Potential Benefits
12 Several large, randomised trials have shown that GLP-1 RAs reduce major adverse cardiovascular events (MACE) compared with placebo
That market grew 300% from the start of 2020 to the end of 2022, according to Trilliant Healths recent trends report
Compounded semaglutide remains the most widely available compounded GLP-1 alternative
Based on current research, its not yet clear if Wegovy or Ozempic passes into human breast milk, and theres no data on the effects on the breastfed baby or the womans milk production, according to the prescribing information
